ÄÜÅÙÃ÷ »ó¼¼º¸±â
¼¼±âÀÇ °úÇÐÀû ºñ¹Ð(ÇÑ¿µÇÕº»)


¼¼±âÀÇ °úÇÐÀû ºñ¹Ð(ÇÑ¿µÇÕº»)

<À±Á¾¿À> Àú | º¸¹ÎÃâÆÇ»ç

Ãâ°£ÀÏ
2024-03-07
ÆÄÀÏÆ÷¸Ë
ePub
¿ë·®
18 M
Áö¿ø±â±â
PC½º¸¶Æ®ÆùÅÂºí¸´PC
ÇöȲ
½Åû °Ç¼ö : 0 °Ç
°£·« ½Åû ¸Þ¼¼Áö
ÄÜÅÙÃ÷ ¼Ò°³
ÀúÀÚ ¼Ò°³
¸ñÂ÷
ÇÑÁÙ¼­Æò

ÄÜÅÙÃ÷ ¼Ò°³

ÀÌ Ã¥À» ÁýÇÊÇÏ°í ÃâÆÇÇϱâ±îÁö ¸¹Àº °í¹ÎÀÌ ÀÖ¾ú´Ù. ÀÌ ºñ¹ÐµéÀÌ ¹àÇôÁ³À» ¶§, ¼¼»ó »ç¶÷µéÀÌ ÀÌ ºñ¹ÐÀÌ Áø½ÇÀÎÁö ¾Æ´ÑÁö ÁøÁöÇÏ°Ô ½ÇÇèÇغ¸°í ÅäÀÇÇغ¼ °ÍÀÎÁö ¾Ë ¼ö ¾ø¾ú±â ¶§¹®¿¡ °¡Áö´Â °í¹ÎÀ̾ú´Ù. ÀÌ Ã¥ÀÇ ³»¿ë¿¡ ´ëÇÑ ÁøÁöÇÑ Á¢±Ù ¾øÀÌ ½ÃÀÛµÉ ¼ö ÀÖ´Â ºñÆǵµ µÎ·Á¿ü´Ù. Àü¹®°¡µéÀÌ ÇØ°áÇØÁÙ °ÍÀ̶ó ¹Ï°í ¼ö³âÀ» ±â´Ù·Áº¸±âµµ Çß´Ù. ±×·¯³ª, ÀÌÁ¦ ½º½º·Î ÇØ°áÇÏÁö ¾Ê´Â ÇÑ ±× ´©±¸µµ ¿ì¸®ÀÇ ¹®Á¦¿¡ ÁøÁ¤¼ºÀ» °¡Áö°í Á¢±ÙÇÏÁö ¾Ê´Â´Ù´Â °ÍÀ» ¾Ë°Ô µÇ¾ú´Ù.
Á¦1ºÎ¿¡¼­´Â ¾ÆÅäÇÇÀÇ ¸ðµç ºñ¹ÐÀ» ÆÄÇìÄ£´Ù. 2022³â Àü ¼¼°è ¾ÆÅäÇÇ ÇǺο° ȯÀÚÀÇ ¼ö´Â 2¾ï 2,300¸¸ ¸í±îÁö Áõ°¡ÇÏ¿´´Ù. ¾ÆÅäÇÇÁõÈıº ȯÀÚ¿¡ ÇØ´çÇϴ õ½Ä, ºñ¿°, °á¸·¿°±îÁö ÇÕÇÏ¸é ±× ¼ýÀÚ´Â Çì¾Æ¸± ¼ö ¾øÀÌ ¸¹¾ÆÁø´Ù. °ú¿¬ Àηù´Â ¾ÆÅäÇÇÀÇ ¿øÀÎÀ» ¸ô¶ó¼­ ¸ø °íÄ¡´Â °ÍÀ̾úÀ»±î? ¾Æ´Ï¸é Àü¹®°¡µéÀÌ ½Ç¼ö¸¦ ÇÏ°í ÀÖ´Â °ÍÀϱî? ¾Æ´Ï¸é °íÀÇ? ¾ÆÅäÇǼº ÇǺο°ÀÇ ¿øÀÎÀÌ ±Ô¸íµÇ°í, ÇØ°áÃ¥ÀÌ ³ª¿Â´Ù´Â °ÍÀº ¸ðµç ¾ÆÅäÇǼº ÇǺο° ȯÀÚ°¡ µ¿ÀÏÇÑ ¹æ¹ýÀ» »ç¿ëÇÏ¿© µ¿ÀÏÇÑ Ä¡·áÈ¿°ú¸¦ ¾ò°Ô µÈ´Ù´Â °ÍÀ» ÀǹÌÇÑ´Ù. ÀÌ´Â ´Ù¸¥ ¾ÆÅäÇÇÁõÈıº ȯÀڵ鵵 Ä¡·áÈ¿°ú¸¦ ±â´ëÇÒ ¼ö ÀÖ°Ô ÇÑ´Ù. ±¹³»¿Ü Á¦¾àȸ»ç Áß ¾ÆÅäÇÇÀÇ ¿øÀÎÀ» ¹àÈ÷·Á´Â Á¦¾àȸ»ç´Â ¾ø´Ù. ´ÜÁö ´«¿¡ ¶ç´Â Áõ¼¼¸¦ È£Àü½ÃÅ°°Å³ª À¯ÁöÇÒ ¾à¹°À» ¿¬±¸ÇÒ »ÓÀÌ´Ù. ¿øÀÎÀ» ¸ø ¹àÈ÷¸é¼­ ¿Ïº®ÇÑ Ä¡·á¸¦ ÇÒ ¼ö Àִ°¡? µàÇÇÁ¨Æ®ÀÇ ¼º°øÀº Ä¡·áÇÏÁö ¾Ê°í Áõ¼¼¸¸ È£Àü½ÃÅ°´Â ¾àÇ°ÀÇ ¼º°øÀ̾ú´Ù. ±×·¸°Ô ´ëÇü Á¦¾à»çµéÀº µàÇÇÁ¨Æ®ÀÇ ¼º°ø ¹æÁ¤½ÄÀ» µû¶ó°¥ »Ó ¾ÆÅäÇÇÀÇ ¿øÀÎÀ» ã¾Æ³»´Â µ¥¿¡´Â ½Ã°£À» ÇÒ¾ÖÇÏÁö ¾Ê¾Ò´Ù. ÀÌÁ¦ ´õ ÀÌ»ó Àü¹®°¡µéÀÌ ¾ÆÅäÇǸ¦ Ä¡·áÇÏ´Â ¹æ¹ýÀ» ãÀ» ¼ö ÀÖÀ¸¸®¶ó´Â ¹ÏÀ½ÀÌ ¾ø¾îÁú ¹«·Æ »õ·Î¿î ¸·¼ö¼Ûü¸¦ ¹ß°ßÇß´Ù. »õ·Î¿î ¸·¼ö¼Ûü´Â ¾ÆÅäÇÇÀÇ ¿øÀÎÀ» ÇǺΠ¹ÛÀ¸·Î ÀεµÇÏ¿© Àΰ£ÀÌ °üÂûÇÒ ¼ö ÀÖµµ·Ï Çß´Ù. ±×¸®°í, Ä¡·á¿ë ¼¼Æ÷ ¼ºÀåÀÎÀÚ¿Í ¼Òµ¶Á¦¸¦ ¼¼Æ÷ ¼ÓÀ¸·Î ¼ö¼ÛÇÏ¿© ¾ÆÅäÇÇ°¡ Ä¡·áµÉ ¼ö ÀÖÀ½À» º¸¿©Áá´Ù.
Á¦2ºÎ¿¡¼­´Â ¡®±âÃʹ°¸®ÇÐÀÇ Èì°á¡¯¿¡ ´ëÇÏ¿© ´Ù·é´Ù. 2023³â Àηù´Â ½É°¢ÇÑ ±âÈÄ º¯È­ÀÇ Á߽ɿ¡ ¼­±â ½ÃÀÛÇß´Ù. ±×·±µ¥µµ Àηù´Â ¾ÆÁ÷ ¿¡³ÊÁö ¹®Á¦¸¦ ÇØ°áÇÏÁö ¸øÇß´Ù. »ý°è¸¦ À§ÇÑ ¿¡³ÊÁöÀÇ ÀÚÀ¯µµ ¾òÁö ¸øÇß°í, ¿¡³ÊÁö¸¦ ±âÈÄ º¯È­ ´ëÀÀ°ú ȯ°æº¸È£¸¦ À§ÇØ »ç¿ëÇÒ Áغñ°¡ µÇ¾îÀÖÁö ¾Ê´Ù. °ú¿¬ Àηù´Â ¿¡³ÊÁö¸¦ ¼ÒºñÇÏ´Â Á¾Á·¿¡¼­ âÁ¶ÇÏ´Â Á¾Á·À¸·Î ÁøÈ­ÇÏÁö ¸øÇÏ´Â °ÍÀϱî? ¿¡³ÊÁö º¸Á¸ÀÇ ¹ýÄ¢Àº ¿µ¿øÈ÷ ±úÁöÁö ¾Ê´Â ¹ýÄ¢Àϱî? ¿¡³ÊÁö°¡ ºÎÁ·Çؼ­ Áö±¸ÀÇ ±âÈÄ º¯È­¿¡ ´ëÀÀÇÏÁö ¸øÇÑ Ã¤·Î Áö±¸ÀÇ È¯°æÀ» °ü¸®ÇÏÁö ¸øÇÏ´Â Á¸Àç·Î ³¡³ª´Â °ÍÀϱî? ºÎÁ·ÇÑ ¿¡³ÊÁö¸¦ ´õ °¡Áö±â À§Çؼ­ ²÷ÀÓ¾øÀÌ ½Î¿ö¾ß ÇÏ´Â Á¾Á·À¸·Î Àηù´Â ±â¾ïµÉ±î? ±âÃʹ°¸®ÇÐÀº ¿¡³ÊÁö¿Í ¾î¶² ¿¬°ü¼ºÀÌ ÀÖÀ»±î? ¡®¾ÆÀν´Å¸ÀÎÀÌ Æ²·È´Ù°í ¸»ÇÒ ¼ö ÀÖ´Â ¿ë±â¡¯ ¡®´ºÅÏÀÌ Æ²·È´Ù°í ¸»ÇÒ ¼ö ÀÖ´Â ¿ë±â¡¯ Àηù¿¡°Ô ±×·± ¿ë±â¿Í ÁöÇý°¡ ÇÊ¿äÇÑ ¶§´Ù.

There were many concerns before writing this book and publishing it. When these secrets were revealed, it was a concern because it was not known whether people in the world would seriously test and discuss whether these secrets were true or not. I was also afraid of criticism that might begin without a serious approach to the contents of this book. I even waited for several years, believing that experts would solve the problem. However, we now know that no one will approach our problems with sincerity unless we solve them ourselves.
In Part 1, we uncover all the secrets of atopy. In 2022, the number of atopic dermatitis patients worldwide increased to 223 million. If you include asthma, rhinitis, and conjunctivitis, which are atopic syndrome patients, the number becomes countless. Could it be that mankind is unable to cure atopy because they do not know the cause? Or are the experts making a mistake? Or intentional? Identifying the cause of atopic dermatitis and finding a solution means that all atopic dermatitis patients will receive the same treatment effect using the same method. This allows other atopic syndrome patients to also expect treatment effects. Among domestic and foreign pharmaceutical companies, no pharmaceutical company is trying to determine the cause of atopy. We simply study drugs that will improve or maintain noticeable symptoms. Is it possible to provide a perfect treatment without being able to identify the cause? The success of Dupixent was the success of a drug that only improved symptoms without treating the disease. In this way, large pharmaceutical companies only followed Dupixent¡¯s formula for success and did not take the time to find the cause of atopy. Just when experts no longer had faith that they could find a way to treat atopy, a new membrane transporter was discovered. The new membrane transporter guides the cause of atopy outside the skin so that it can be observed by humans. Additionally, they showed that atopic dermatitis can be treated by transporting therapeutic cell growth factors and disinfectants into cells.
Part 2, deals with ¡®flaws in basic physics.¡¯ In 2023, humanity begins to find itself at the center of severe climate change. However, humanity has not yet solved the energy problem. We have not achieved freedom of energy for livelihood and are not prepared to use energy to respond to climate change and protect the environment. Is it true that humanity cannot evolve from a species that consumes energy to a species that creates energy? Is the law of conservation of energy unbreakable? Will we end up unable to manage the Earth¡¯s environment due to lack of energy and unable to respond to climate change? Will humanity be remembered as a species that must constantly fight to have more energy? How does basic physics relate to energy? ¡®The courage to say that Einstein was wrong¡¯ ¡®The courage to say that Newton was wrong¡¯ This is a time when humanity needs such courage and wisdom.

ÀúÀÚ¼Ò°³

¹°ÁúÀÌ¿Â ¿¬±¸ Àü¹®°¡
- ƼŸ´½ ÀÌ¿Â °³¹ß
- Áö¸£ÄÚ´½ ÀÌ¿Â °³¹ß
- ¼·Ãë °¡´ÉÇÑ ±Ô¼Ò ÀÌ¿Â °³¹ß

ÇÊÀÚ´Â ¼·Ãë °¡´ÉÇÑ À¯±â±Ô¼Ò À̿¾×À» °³¹ß ¹× ÆǸÅÇß´Ù´Â ÀÌÀ¯·Î ¹ý¿øÀ¸·ÎºÎÅÍ Â¡¿ª 8°³¿ù¿¡ ÁýÇàÀ¯¿¹ 2³âÀ» ¼±°í¹Þ¾Ò´Ù.
The author was sentenced to 8 months in prison and 2 years of probation by the court for developing and selling ingestible organosilicon ionic liquid.

¸ñÂ÷

ÇÁ·Ñ·Î±×(Prologue)


Á¦1ºÎ. ¸·¼ö¼Ûü ¹ß°ßÀ¸·Î ¹àÇôÁø ¾ÆÅäÇÇÀÇ Áø½Ç
Á¦1ºÎ. The truth about atopy revealed through the discovery of a new membrane transporte

¾ÆÅäÇÇÀÇ ºñ¹ÐÀ» ¹àÈ÷´Â ¹Ø°Å¸§
The foundation for revealing the secrets of atopy

¾ÆÅäÇÇ ÁõÈıº
atopic syndrome

¾ÆÅäÇÇ ÇǺο°
Atopic dermatitis

¾Ë·¹¸£±â¼º ºñ¿°
Allergic rhinitis

¾ÆÅäÇÇÁõÈıºÀÇ ÀÚ°¡¸é¿ªÁúȯ ¿©ºÎ¿¡ ´ëÇÑ °íÂû
Consideration on whether atopy syndrome is an autoimmune disease

Àΰ£ ÀÌ¿ÜÀÇ µ¿¹°¿¡ ¹ß»ýÇÏ´Â ¾ÆÅäÇÇ À¯»çÇö»ó ¶Ç´Â ¸¶ÀÌÄÚÇöóÁ±Õ °¨¿°Áõ
Atopy-like phenomenon or mycoplasma infection that occurs in animals other than humans

¸¶ÀÌÄÚÇöóÁ±Õ â±ÈÀÇ ¿øÀÎ
Causes of Mycoplasma outbreaks on a large scale

Á¾·¡ NC/Nga mouse(¾ÆÅäÇÇ ÇǺο°) ½ÇÇèÀÇ ½ÇÆÐ ÀÌÀ¯
Reasons for failure of conventional NC/Nga mouse (atopic dermatitis) experiment

¸¶ÀÌÄÚÇöóÁ±ÕÀÇ ½À¼º
Habits of Mycoplasma

°¨¿°°æ·Î
Infection route

¾ÆÅäÇÇ ÇǺο°ÀÇ À¯Àü ÀǽÉ
Suspected inheritance of atopic dermatitis

¼¼Æ÷ ³» ±â»ýÃæ
Intracellular parasites

Áö±Ý±îÁö ¾ÆÅäÇÇÀÇ Ä¡·á°¡ ¾î·Á¿ü´ø ÀÌÀ¯
The reason why atopy has been difficult to treat until now

¾ÆÅäÇÇÁõÈıº ¹× ¼¼Æ÷ ³» ±â»ýÃæ¿¡ ÀÇÇÑ ÇǺÎÁúȯ Ä¡·á¹æ¹ý¿¡ ´ëÇÑ ¿¬±¸
Research on treatment methods for atopic syndrome and skin diseases caused by intracellular parasites

ÀÌ¿Âä³Î°ú ¸·¼ö¼Ûü
Ion channels and membrane transporters

¼¼Æ÷ÀÇ Ä¡·á¸¦ À§ÇÑ ¼ººÐ 1 ? ¼ºÀåÀÎÀÚ
Ingredient 1 for cell treatment ? cell growth factors

¼¼Æ÷ÀÇ Ä¡·á¸¦ À§ÇÑ ¼ººÐ 2 ? À¯È²(Sulfur) ¼ººÐÀ» ÇÔÀ¯ÇÑ ¼Òµ¶Á¦
Ingredient 2 for cell treatment ? Disinfectant containing sulfur

[½Ç½Ã¿¹] 1. ÇǺÎÁúȯ Ä¡·á¿ë Á¶¼º¹° Á¦Á¶
[Example] 1. Preparation of composition for treating skin diseases

[Àû¿ë·Ê] 1. ¼ºÀÎ ¾ÆÅäÇÇ ÇǺο°
[Application example] 1. Adult atopic dermatitis

[Àû¿ë·Ê] 2. ¼ºÀÎ ¾ÆÅäÇÇ ÇǺο°
[Application example] 2. Adult atopic dermatitis

[Àû¿ë·Ê] 3. ¼ºÀÎ ¾ÆÅäÇÇ ÇǺο°
[Application example] 3. Adult atopic dermatitis

[Àû¿ë·Ê] 4. ¼ºÀÎ ¾ÆÅäÇÇ ÇǺο° 4°³¿ù »ç¿ë
[Application example] 4. Adult atopic dermatitis: 4 months of use

[Àû¿ë·Ê] 5. È­Æó»ó ½ÀÁø
[Application example] 5. Numismatic eczema

[½Ç½Ã¿¹] 3. Ȳ(Sulfur) ¼ººÐÀÇ »ì±ÕÁ¦¸¦ Æ÷ÇÔÇÑ ÇǺÎÁúȯ Ä¡·á¿ë Á¶¼º¹° Á¦Á¶
[Example] 3. Preparation of a composition for treating skin diseases containing a sulfur-containing disinfectant

[Àû¿ë·Ê] 6. ÁßÁõ ¾ÆÅäÇÇ È¯ÀÚ ? Ȳ(Sulfur) ¼ººÐÀ» Æ÷ÇÔÇÑ ÇǺÎÁúȯ Ä¡·á¿ë Á¶¼º¹° Àû¿ë·Ê
[Application example] 6. Patients with severe atopy ? Example of application of a composition for treating skin diseases containing sulfur ingredients

¿£µµÅå½Å
Endotoxin

ºÎ·Ï 1 : ¸ÅÀÏ°æÁ¦(www.mk.co.kr) ½Å¹® ±â»ç³»¿ë ¹× ¿µ¹®¹ø¿ª
Appendix 1: Maeil Business Newspaper (www.mk.co.kr) newspaper article content and English translation

ºÎ·Ï 2: ºñ¿°È¯ÀÚÀÇ ¾ÆÅäÇÇ ¹ßÇö ¹× Ä¡·á»ç·Ê
Appendix 2: Cases of atopy presentation and treatment in rhinitis patients

ȯÀÚÀÇ Ä¡·á Àü ±âÃÊÀÚ·á
Patient¡¯s basic data before treatment

ù ¹ø° Á¶Ä¡»çÇ×°ú ±× °á°ú
First actions and results

¿¹»óÄ¡ ¸øÇÑ Çö»ó¿¡ ´ëÇÑ Á¶Ä¡»çÇ×°ú ±× °á°ú
Measures and results for unexpected phenomena

¼¼ ¹ø° Á¶Ä¡»çÇ×°ú ±× °á°ú
Third action and its results

³× ¹ø° Á¶Ä¡»çÇ×°ú ±× °á°ú
Fourth action and its results

´Ù¼¸ ¹ø° Á¶Ä¡»çÇ×°ú ±× °á°ú
Fifth action and its results

ºÎ·Ï 3: ¾ÆÅäÇÇ ÇǺο° °¡·Á¿òÁõ¸¸ Ä¡·áÇÑ Ä¡·á»ç·Ê
Appendix 3: Case study that only treated atopic dermatitis itching

ºÎ·Ï 4: ¾ÆÅäÇÇ ÇǺο° ±ÇÀå Ä¡·á¹æ¹ý¿¡ °üÇÑ ¾È³»
Appendix 4: Information on recommended treatment methods for atopic dermatitis

ºÎ·Ï 5: ÀϹÝÀûÀÎ À¯±â±Ô¼ÒÀÌ¿Â »ç¿ë»ç·Ê
Appendix 5: Common Chelated Silicon Ion Use Cases

ºÎ·Ï 6: À¯±â±Ô¼ÒÀÇ ¿ª»ç
Appendix 6: History of organosilicon

Á¦1ºÎ¸¦ ¸¶Ä¡¸ç¡¦
Concluding Part 1¡¦


Á¦2ºÎ. ±âÃʹ°¸®ÇÐÀÇ Èì°á
Flaws in basic physics

°ü³äÀÌ Çö½ÇÀ» Áö¹èÇÏ´Â ¼¼»ó
A world where ideas dominate reality

´ºÅÏ°ú ¾ÆÀν´Å¸ÀÎ
Newton and Einstein

´ºÅÏÀÇ °¡¼ÓµµÀÇ ¹ýÄ¢ÀÇ Èì°á
Flaws in Newton¡¯s law of acceleration

¾ÆÀν´Å¸ÀÎÀÇ Áú·® Áõ°¡À̷аú Áú·® Áõ°¡°ø½ÄÀÇ Èì°á
Flaws in Einstein¡¯s mass increase theory and mass increase formula

±âÃʹ°¸®ÇÐÀÇ Èì°á °á¿©
Resolving the flaws in basic physics

¿îµ¿¿¡³ÊÁö
Kinetic energy

¿£Æ®·ÎÇÇ ¹ýÄ¢°ú °ü¼ºÀÇ ¹ýÄ¢
Law of Entropy and Law of Inertia

¿¡³ÊÁö º¸Á¸ÀÇ ¹ýÄ¢
Law of conservation of energy

°ü¼ºÀº ¾î¶»°Ô ´©ÀûµÇ´Â°¡?
How does inertia accumulate?


ºÎ·Ï(supplement)

·»Ã÷ÀÇ ¹ýÄ¢
Lenz¡¯s law

¿µÁ¡¿¡³ÊÁö
Zero point energy

¼ö¼Ò°¡ ÁÖ´Â ±³ÈÆ
Lessons from hydrogen

±¤ÀÚ´Â Áú·®ÀÌ Àִ°¡?
Do photons have mass?

ÈûÀÇ ´ÜÀ§´Â »ç¿ëÇÒ ¼ö ÀÖ´Â ´ÜÀ§Àΰ¡?
Is the unit of force usable?


¿¡Çʷα×(Epilogue)